Giant Med

Medical Devices & EquipmentSeries ABeijing, China

Latest round

Series A

Last raised

Aug 2024

Total raised

$14M

Investors

3

About Giant Med

Based in Beijing, China and founded in 2022, Giant Med is an ophthalmology group company that focuses on providing medical testing services and ophthalmic precision diagnostic and treatment products. It was founded by Dr. Yong Tao and has a subsidiary, named as Zhi De Ming Chuang. The company's headquarters and laboratories are located in Beijing, and it has a research and development department in Wuxi. The frim acquired the honorary title of Ophthalmology Science and Technology Progress. The company focuses on the field of ophthalmology and provides medical testing services. Its services have covered more than 1100 hospitals across the country. Its subsidiary Zhide Mingchuang, mainly develops and produces ophthalmic diagnostic reagents, Its products are divided into four product lines: immunodiagnosis, molecular diagnosis, medical devices and core proteins, including monkeypox antigen detection kit, human cytomegalovirus nucleic acid detection kit, single chemiluminescent immunoassay analyzer, mouse anti-human IgE monoclonal antibody and other products. The company generates revenue by developing and selling ophthalmic diagnostic reagents, medical devices and drugs.

Who invested in Giant Med

3 investors across 1 round

See all investors in Giant Med

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series A

    Aug 10, 2024

    Amount

    $14M

    Investors

    Locked

Questions about Giant Med

Who invested in Giant Med?

Giant Med has 3 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Giant Med raised?

Giant Med has raised 1 venture round. Sign up free to see how much each round raised and the total.

When did Giant Med last raise money?

Giant Med's most recent round on record is a Series A, in Aug 2024.

What does Giant Med do?

Based in Beijing, China and founded in 2022, Giant Med is an ophthalmology group company that focuses on providing medical testing services and ophthalmic precision diagnostic and treatment products.

Where is Giant Med headquartered?

Giant Med is headquartered in Beijing, China.

Which VCs invest in companies like Giant Med?

Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back medical devices & equipment companies at Giant Med's stage. Their profiles are linked below.

Raising like Giant Med? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.